SLS

SELLAS Announces Executive Leadership Reorganization and Prioritization of Commercialization Partnerships

Retrieved on: 
Friday, March 8, 2024

As part of this effort, Senior Vice President, Chief Commercial Officer, Robert Francomano and Executive Vice President, General Counsel and Corporate Secretary, Barbara Wood, will be departing the Company.

Key Points: 
  • As part of this effort, Senior Vice President, Chief Commercial Officer, Robert Francomano and Executive Vice President, General Counsel and Corporate Secretary, Barbara Wood, will be departing the Company.
  • “As part of our efforts to rapidly advance our clinical pipeline, we continue to streamline our operations to effectively and efficiently deliver on our key business objectives,” said Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS.
  • “As I mentioned on the January shareholder call, our focus remains on shareholder value through the development of our assets and tight financial stewardship and exploration of commercial partnerships with the assistance of Stifel Financial Corp.
  • Stacy Yeung, recently promoted to Vice President, Associate General Counsel, and Head of Compliance, with 20 years of relevant experience will lead the Company’s legal and compliance functions.

Solaris Announces Cooperation Agreement with Interprovincial Federation of Shuar Centers and the Alliance for Entrepreneurship and Innovation of Ecuador

Retrieved on: 
Friday, March 1, 2024

VANCOUVER, British Columbia, March 01, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to announce a trilateral cooperation agreement with the Interprovincial Federation of Shuar Centers (“FICSH”) and the Alliance for Entrepreneurship and Innovation (“AEI”) of Ecuador, with the signing ceremony to take place over PDAC.

Key Points: 
  • VANCOUVER, British Columbia, March 01, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to announce a trilateral cooperation agreement with the Interprovincial Federation of Shuar Centers (“FICSH”) and the Alliance for Entrepreneurship and Innovation (“AEI”) of Ecuador, with the signing ceremony to take place over PDAC.
  • FICSH is the highest authority and largest Shuar indigenous organization legally established by statute of the Ministry of Social Welfare of Ecuador in 1964 and includes 50 associations comprising 500 Shuar communities and approximately 143,000 Shuar indigenous people.
  • AEI is an independent non-profit dedicated to promoting entrepreneurship and innovation as the basis for the productive development of Ecuador.
  • The organization represents a network of public, private and academic actors of which Solaris has been a member since 2021.

SELLAS Life Sciences Delivers Oral Presentation of SLS009 Phase 1 Data for Acute Myeloid Leukemia Patients at 2024 European School of Haematology (ESH) Conference

Retrieved on: 
Friday, March 1, 2024

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced the delivery of an oral presentation of data for the cohort of patients with acute myeloid leukemia (AML) from the Phase 1 dose-escalation study of SLS009 (formerly GFH009) by Dr. Tapan Kadia, Professor at MD Anderson Cancer Center and the study’s primary investigator, at the 2024 European School of Haematology Acute Leukaemias (ESH) Conference: How to Diagnose and Treat Acute Leukaemias, taking place March 1-3, 2024, in Stockholm, Sweden.

Key Points: 
  • Positive topline data for the heavily pretreated AML patients showed evidence of anti-tumor activity increasing with higher dose levels and no significant safety issues.
  • The CR lasted eight months with the patient achieving one year survival at the latest assessment.
  • Strong inhibitory activity against key biomarkers with a dose-proportional response and universal decrease of MYC and MCL-1 in evaluable patients.
  • “Its potential strong synergy with the standard regimen of venetoclax and hypomethylating agents could open up new avenues in the treatment of acute myeloid leukemia.

SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference: Updated Date and Time

Retrieved on: 
Thursday, February 29, 2024

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the date and time for the presentation of data from the acute myeloid leukemia cohort of patients in the Phase 1 dose-escalation study of SLS009 (formerly GFH009) will be presented in an oral presentation at the 2024 European School of Haematology Acute Leukaemias (ESH) Conference: How to Diagnose and Treat Acute Leukaemias, taking place March 1-3, 2024, in Stockholm, Sweden has changed from Sunday, March 3, 2024 at 12 pm CEST to Friday March 1, 2024 at 12:55 pm CEST.

Key Points: 
  • NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the date and time for the presentation of data from the acute myeloid leukemia cohort of patients in the Phase 1 dose-escalation study of SLS009 (formerly GFH009) will be presented in an oral presentation at the 2024 European School of Haematology Acute Leukaemias (ESH) Conference: How to Diagnose and Treat Acute Leukaemias, taking place March 1-3, 2024, in Stockholm, Sweden has changed from Sunday, March 3, 2024 at 12 pm CEST to Friday March 1, 2024 at 12:55 pm CEST.
  • The presentation details are below:
    Presenter: Dr. Tapan Kadia, Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas

3D Printing High-Performance Plastics Market to Reach $520.0 Million by 2028: BCC Research

Retrieved on: 
Friday, March 8, 2024

BOSTON, March 8, 2024 /PRNewswire/ -- "According to the latest BCC Research study, the demand for Global 3D Printing High-Performance Plastics Market is estimated to increase from $163.6 million in 2022 to reach $520.0 million by 2028, at a compound annual growth rate (CAGR) of 21.4% from 2022 through 2028."

Key Points: 
  • BOSTON, March 8, 2024 /PRNewswire/ -- "According to the latest BCC Research study, the demand for Global 3D Printing High-Performance Plastics Market is estimated to increase from $163.6 million in 2022 to reach $520.0 million by 2028, at a compound annual growth rate (CAGR) of 21.4% from 2022 through 2028."
  • This comprehensive report focuses specifically on high-performance plastics within the expansive 3D printing industry, highlighting key materials such as polyamide, polyetherimide, polyetheretherketone, polyetherketoneketone, polyvinylidene difluoride, and polyphenylsulfone.
  • The forecasted revenue projections from 2022 to 2028 encompass each type, technology, end-user, and regional segment, offering a comprehensive outlook on the evolving landscape of the 3D printing high-performance plastics market.
  • The intersection of digitalization, robotics, and the growing demand for personalized, point-of-care medical solutions is fueling a surge in high-performance plastics (HPP) adoption in 3D printing.

Dental 3D Printing Market Size to Grow USD 1328.2 Million by 2030 at a CAGR of 16% | Valuates Reports

Retrieved on: 
Thursday, March 7, 2024

BANGALORE, India, March 7, 2024 /PRNewswire/ -- The Global Dental 3D Printing Market was valued at USD 464.5 Million in 2023 and is anticipated to reach USD 1328.2 Million by 2030, witnessing a CAGR of 16.0% during the forecast period 2024-2030.

Key Points: 
  • BANGALORE, India, March 7, 2024 /PRNewswire/ -- The Global Dental 3D Printing Market was valued at USD 464.5 Million in 2023 and is anticipated to reach USD 1328.2 Million by 2030, witnessing a CAGR of 16.0% during the forecast period 2024-2030.
  • The capability of customizing dental items to meet the needs of individual patients is another important factor propelling the growth of the dental 3D printing market.
  • A practical and affordable way to produce high-precision and accurate dentures, bridges, and crowns is through dental 3D printing.
  • The dental 3D printing market share in North America was almost 34%.

Dental 3D Printing Market Size to Grow USD 1328.2 Million by 2030 at a CAGR of 16% | Valuates Reports

Retrieved on: 
Thursday, March 7, 2024

BANGALORE, India, March 7, 2024 /PRNewswire/ -- The Global Dental 3D Printing Market was valued at USD 464.5 Million in 2023 and is anticipated to reach USD 1328.2 Million by 2030, witnessing a CAGR of 16.0% during the forecast period 2024-2030.

Key Points: 
  • BANGALORE, India, March 7, 2024 /PRNewswire/ -- The Global Dental 3D Printing Market was valued at USD 464.5 Million in 2023 and is anticipated to reach USD 1328.2 Million by 2030, witnessing a CAGR of 16.0% during the forecast period 2024-2030.
  • The capability of customizing dental items to meet the needs of individual patients is another important factor propelling the growth of the dental 3D printing market.
  • A practical and affordable way to produce high-precision and accurate dentures, bridges, and crowns is through dental 3D printing.
  • The dental 3D printing market share in North America was almost 34%.

MIRRORLESS GOES TO THE MOON: NIKON ENTERS INTO SPACE ACT AGREEMENT WITH NASA FOR ARTEMIS MISSION SUPPORT WITH THE NIKON Z 9 CAMERA

Retrieved on: 
Thursday, February 29, 2024

MELVILLE, N.Y., Feb. 29, 2024 /PRNewswire/ -- Nikon Inc. has entered into a Space Act agreement with the National Aeronautics and Space Administration (NASA) to support the agency's Artemis campaign with the Handheld Universal Lunar Camera (HULC) development. The Nikon Z 9, Nikon's mirrorless full-frame flagship, as implemented in the HULC system, will be the handheld camera for the upcoming Artemis III mission which will be used by the crew returning to the surface of the Moon.

Key Points: 
  • MELVILLE, N.Y., Feb. 29, 2024 /PRNewswire/ -- Nikon Inc. has entered into a Space Act agreement with the National Aeronautics and Space Administration (NASA) to support the agency's Artemis campaign with the Handheld Universal Lunar Camera (HULC) development.
  • The Nikon Z 9, Nikon's mirrorless full-frame flagship, as implemented in the HULC system, will be the handheld camera for the upcoming Artemis III mission which will be used by the crew returning to the surface of the Moon.
  • The Artemis III mission is scheduled to launch NASA's SLS (Space Launch System) rocket with the agency's Orion spacecraft in September 2026.
  • To help capture imagery, the mission has the need for a common camera platform to reduce overall mass and development efforts while simplifying training and increasing efficiency.

Monster Energy Returns To Street League Skateboarding With a New Multi-Year Partnership Agreement

Retrieved on: 
Thursday, February 15, 2024

LAS VEGAS, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Street League Skateboarding (SLS) and Monster Energy announced a multi-year partnership agreement today. Monster Energy, a foundational partner of the global skateboarding competition series since its inception in 2010, returns to SLS with excitement over the growth of the league, especially the expanded season and new formats.

Key Points: 
  • Street League Skateboarding (SLS) and Monster Energy announced a multi-year partnership agreement today.
  • LAS VEGAS, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Street League Skateboarding (SLS) and Monster Energy announced a multi-year partnership agreement today.
  • Monster Energy is stoked to support the future of SLS and skateboarding with this renewed partnership," said Mitch Covington, SVP of Sports Marketing at Monster Energy.
  • For more Street League Skateboarding news, including updates on the Championship Tour, go to http://www.streetleague.com and follow Street League Skateboarding on Instagram and Facebook.

Spinning the Future of Clean: Cleancult Debuts One-of-a-Kind Laundry Detergent Sheets Leaving Bulky Plastic Bottles Behind

Retrieved on: 
Tuesday, February 13, 2024

NEW YORK, Feb. 13, 2024 /PRNewswire/ -- Cleancult is solidifying its position as a leader in the plastic waste retail sector with the launch of the world's first concentrated laundry detergent sheets that contain three stain-fighting enzymes to deliver a uniquely powerful clean. Available for purchase on www.Cleancult.com and Amazon, then landing at select Walmart stores nationwide in April and other retailers later this year, the conveniently pre-measured and lightweight sheets come in an innovative 100% plastic-free and recyclable paper drawer box, eliminating the need for wasteful single-use plastic bottles.

Key Points: 
  • Anti-plastic waste cleaning brand powers sustainable laundry cycles with the launch of triple-action laundry sheets, featuring three stain-expelling enzymes on Amazon and at Walmart.
  • "We have taken a mighty, not messy approach with our latest liquidless laundry lineup.
  • "The powerful formula and compact design make these clean sheets the perfect addition to laundry routines and are great to use when traveling."
  • Leaving clothes soft and fresh, the dissolvable sheets are always made without harsh chemicals, including dyes, phosphates, 1,4-dioxane, phthalates, parabens, phosphorus, and SLS.